199 related articles for article (PubMed ID: 31000628)
1. The redox regulator sulfiredoxin forms a complex with thioredoxin domain-containing 5 protein in response to ER stress in lung cancer cells.
Chawsheen HA; Jiang H; Ying Q; Ding N; Thapa P; Wei Q
J Biol Chem; 2019 May; 294(22):8991-9006. PubMed ID: 31000628
[TBL] [Abstract][Full Text] [Related]
2. Cetuximab enhances cisplatin-induced endoplasmic reticulum stress-associated apoptosis in laryngeal squamous cell carcinoma cells by inhibiting expression of TXNDC5.
Peng F; Zhang H; Du Y; Tan P
Mol Med Rep; 2018 Mar; 17(3):4767-4776. PubMed ID: 29328423
[TBL] [Abstract][Full Text] [Related]
3. Tumor promoter-induced sulfiredoxin is required for mouse skin tumorigenesis.
Wu L; Jiang H; Chawsheen HA; Mishra M; Young MR; Gerard M; Toledano MB; Colburn NH; Wei Q
Carcinogenesis; 2014 May; 35(5):1177-84. PubMed ID: 24503444
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factor E2-related factor 2 dependent overexpression of sulfiredoxin and peroxiredoxin III in human lung cancer.
Kim YS; Lee HL; Lee KB; Park JH; Chung WY; Lee KS; Sheen SS; Park KJ; Hwang SC
Korean J Intern Med; 2011 Sep; 26(3):304-13. PubMed ID: 22016591
[TBL] [Abstract][Full Text] [Related]
5. Sulfiredoxin-Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling.
Wei Q; Jiang H; Xiao Z; Baker A; Young MR; Veenstra TD; Colburn NH
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7004-9. PubMed ID: 21487000
[TBL] [Abstract][Full Text] [Related]
6. Sulfiredoxin protein is critical for redox balance and survival of cells exposed to low steady-state levels of H2O2.
Baek JY; Han SH; Sung SH; Lee HE; Kim YM; Noh YH; Bae SH; Rhee SG; Chang TS
J Biol Chem; 2012 Jan; 287(1):81-89. PubMed ID: 22086924
[TBL] [Abstract][Full Text] [Related]
7. Endoplasmic Reticulum Protein TXNDC5 Augments Myocardial Fibrosis by Facilitating Extracellular Matrix Protein Folding and Redox-Sensitive Cardiac Fibroblast Activation.
Shih YC; Chen CL; Zhang Y; Mellor RL; Kanter EM; Fang Y; Wang HC; Hung CT; Nong JY; Chen HJ; Lee TH; Tseng YS; Chen CN; Wu CC; Lin SL; Yamada KA; Nerbonne JM; Yang KC
Circ Res; 2018 Apr; 122(8):1052-1068. PubMed ID: 29535165
[TBL] [Abstract][Full Text] [Related]
8. High TXNDC5 expression predicts poor prognosis in renal cell carcinoma.
Mo R; Peng J; Xiao J; Ma J; Li W; Wang J; Ruan Y; Ma S; Hong Y; Wang C; Gao K; Fan J
Tumour Biol; 2016 Jul; 37(7):9797-806. PubMed ID: 26810069
[TBL] [Abstract][Full Text] [Related]
9. Role of TXNDC5 in tumorigenesis of colorectal cancer cells: In vivo and in vitro evidence.
Tan F; Zhu H; He X; Yu N; Zhang X; Xu H; Pei H
Int J Mol Med; 2018 Aug; 42(2):935-945. PubMed ID: 29749460
[TBL] [Abstract][Full Text] [Related]
10. Effective killing of cancer cells and regression of tumor growth by K27 targeting sulfiredoxin.
Kim J; Lee GR; Kim H; Jo YJ; Hong SE; Lee J; Lee HI; Jang YS; Oh SH; Lee HJ; Lee JS; Jeong W
Free Radic Biol Med; 2016 Dec; 101():384-392. PubMed ID: 27825965
[TBL] [Abstract][Full Text] [Related]
11. Sulfiredoxin May Promote Cervical Cancer Metastasis via Wnt/β-Catenin Signaling Pathway.
Lan K; Zhao Y; Fan Y; Ma B; Yang S; Liu Q; Linghu H; Wang H
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448437
[TBL] [Abstract][Full Text] [Related]
12. Sulfiredoxin inhibitor induces preferential death of cancer cells through reactive oxygen species-mediated mitochondrial damage.
Kim H; Lee GR; Kim J; Baek JY; Jo YJ; Hong SE; Kim SH; Lee J; Lee HI; Park SK; Kim HM; Lee HJ; Chang TS; Rhee SG; Lee JS; Jeong W
Free Radic Biol Med; 2016 Feb; 91():264-74. PubMed ID: 26721593
[TBL] [Abstract][Full Text] [Related]
13. Peroxiredoxin III and sulfiredoxin together protect mice from pyrazole-induced oxidative liver injury.
Bae SH; Sung SH; Lee HE; Kang HT; Lee SK; Oh SY; Woo HA; Kil IS; Rhee SG
Antioxid Redox Signal; 2012 Nov; 17(10):1351-61. PubMed ID: 22490042
[TBL] [Abstract][Full Text] [Related]
14. Sulfiredoxin Promotes Colorectal Cancer Cell Invasion and Metastasis through a Novel Mechanism of Enhancing EGFR Signaling.
Jiang H; Wu L; Chen J; Mishra M; Chawsheen HA; Zhu H; Wei Q
Mol Cancer Res; 2015 Dec; 13(12):1554-66. PubMed ID: 26290602
[TBL] [Abstract][Full Text] [Related]
15. Sulfiredoxin involved in the protection of peroxiredoxins against hyperoxidation in the early hyperglycaemia.
Shi S; Guo Y; Lou Y; Li Q; Cai X; Zhong X; Li H
Exp Cell Res; 2017 Mar; 352(2):273-280. PubMed ID: 28202395
[TBL] [Abstract][Full Text] [Related]
16. New insights on the differential interaction of sulfiredoxin with members of the peroxiredoxin family revealed by protein-protein docking and experimental studies.
Mishra M; Jiang H; Wei Q
Eur J Pharmacol; 2023 Sep; 954():175873. PubMed ID: 37353187
[TBL] [Abstract][Full Text] [Related]
17. Deglutathionylation of 2-Cys peroxiredoxin is specifically catalyzed by sulfiredoxin.
Park JW; Mieyal JJ; Rhee SG; Chock PB
J Biol Chem; 2009 Aug; 284(35):23364-74. PubMed ID: 19561357
[TBL] [Abstract][Full Text] [Related]
18. Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine.
Chang TS; Jeong W; Woo HA; Lee SM; Park S; Rhee SG
J Biol Chem; 2004 Dec; 279(49):50994-1001. PubMed ID: 15448164
[TBL] [Abstract][Full Text] [Related]
19. Sulfiredoxin Promotes Cancer Cell Invasion through Regulation of the miR143-Fascin Axis.
Jiang H; Thapa P; Ding N; Hao Y; Alshahrani A; Wang C; Evers BM; Wei Q
Mol Cell Biol; 2022 May; 42(5):e0005122. PubMed ID: 35412358
[TBL] [Abstract][Full Text] [Related]
20. The contribution of NADPH thioredoxin reductase C (NTRC) and sulfiredoxin to 2-Cys peroxiredoxin overoxidation in Arabidopsis thaliana chloroplasts.
Puerto-Galán L; Pérez-Ruiz JM; Guinea M; Cejudo FJ
J Exp Bot; 2015 May; 66(10):2957-66. PubMed ID: 25560178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
